Drug Master Files for: AMPRENAVIR
✉ Email this page to a colleague
AMPRENAVIR Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 13060 | I | II | 7/7/1998 | CATALENT FRANCE BEINHEIM SA | AMPRENAVIR 50 AND 150 MG SOFT GELATIN CAPSULES |
| 25569 | A | II | 2/24/2012 | LUPIN LTD | FOSAMPRENAVIR CALCIUM |
| 25578 | A | II | 11/29/2011 | MYLAN LABORATORIES LTD | FOSAMPRENAVIR CALCIUM |
| 25649 | I | II | 1/16/2012 | SUN PHARMACEUTICAL INDUSTRIES LTD | FOSAMPRENAVIR CALCIUM |
| 27593 | A | II | 3/20/2014 | TEVA PHARMACEUTICAL INDUSTRIES LTD | FOSAMPRENAVIR CALCIUM |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
